Skip to main content

Advertisement

SpringerLink
Log in

The new liver epidemic

  • News Feature
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

NASH has replaced hepatitis C as the most important nonalcoholic liver disease. Biotech and pharma are racing to tap into this enormous market.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Perry, R. J., Samuel, V. T., Petersen, K. F. & Shulman, G. I. Nature 510, 84–91 (2014).

    Article  CAS  Google Scholar 

  2. Sanyal, A. J. et al. N. Engl. J. Med. 362, 1675–1685 (2010).

    Article  CAS  Google Scholar 

  3. Huang, M. A. et al. Am. J. Gastroenterol. 100, 1072–1081 (2005).

    Article  Google Scholar 

  4. Promrat, K. et al. Hepatology 51, 121–129 (2010).

    Article  CAS  Google Scholar 

  5. Parks, D. J. et al. Science 284, 1365–1368 (1999).

    Article  CAS  Google Scholar 

  6. Holt, J. A. et al. Genes Dev. 17, 1581–1591 (2003).

    Article  CAS  Google Scholar 

  7. Neuschwander-Tetri, B. A. et al. Lancet 385, 956–965 (2015).

    Article  CAS  Google Scholar 

  8. Loomba, R. et al. Hepatology 67, 549–559 (2018).

    Article  CAS  Google Scholar 

  9. Pawlak, M. et al. Hepatology 60, 1593–1606 (2014).

    Article  CAS  Google Scholar 

  10. Ratziu, V. et al. Gastroenterology 150, 1147–1159 (2016).

    Article  CAS  Google Scholar 

  11. Friedman, S. L. et al. Hepatology 67, 1754–1767 (2018).

    Article  CAS  Google Scholar 

  12. Armstrong, M. J. et al. Lancet 387, 679–690 (2016).

    Article  CAS  Google Scholar 

  13. Patel, K. et al. Hepatology 68 (Suppl. 1), 438A, abstract 736 (2018).

  14. Luo, J. et al. Sci. Transl. Med. 6, 247ra100 (2014).

    Article  Google Scholar 

  15. Harrison, S. A. et al. Lancet 391, 1174–1185 (2018).

    Article  CAS  Google Scholar 

  16. Romeo, S. et al. Nat. Genet. 40, 1461–1465 (2008).

    Article  CAS  Google Scholar 

  17. Yuan, X. et al. Am. J. Hum. Genet. 83, 520–528 (2008).

    Article  CAS  Google Scholar 

  18. Linden D. et al. Hepatology 68 (Supp. 1), 440A, abstract 740 (2018).

  19. Kozlitina, J. et al. Nat. Genet. 46, 352–356 (2014).

    Article  CAS  Google Scholar 

  20. Abul-Husn, N. S. et al. N. Engl. J. Med. 378, 1096–1106 (2018).

    Article  CAS  Google Scholar 

  21. Ma, Y. et al. Hepatology https://doi.org/10.1002/hep.30350 (2018).

  22. About, F., Abel, L. & Cobat, A. N. Engl. J. Med. 379, 1875–1876 (2018).

Download references

Author information

Authors and Affiliations

  1. Ken Garber is a freelance reporter based in Ann Arbor, Michigan, USA

    Ken Garber

Authors
  1. Ken Garber
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Garber, K. The new liver epidemic. Nat Biotechnol 37, 209–214 (2019). https://doi.org/10.1038/s41587-019-0047-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41587-019-0047-9

  • Springer Nature America, Inc.

This article is cited by

Search

Navigation